Optimizing neoral therapeutic drug monitoring with cyclosporine trough (C 0 ) and C 2 concentrations in stable renal allograft recipients

By Einecke G.   Mai I.   Diekmann F.   Fritsche L.   Boehler T.   Neumayer H.-H.   Budde K.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3102-3103

Elsevier

Access to resources Recommend Favorite

Assessment of cyclosporine therapeutic monitoring with C 2 concentrations in stable renal allograft recipients

By Diaz J.M.   Sainz Z.   Guirado L.L.   Montanes R.   Picazo M.   Garcia-Camin R.   Alcaraz A.   Sola R.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1783-1784

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Inigo V.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2259-2260

Elsevier

Access to resources Recommend Favorite

Risk of Acute Cellular Rejection After Azathioprine Withdrawal in Stable Renal Allograft Recipients on Cyclosporine, Azathioprine, and Prednisone

By Fabrega A.J.   Roy G.   Reynolds L.   Corwin C.   Hunsicker L.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1335-1336

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Marcas L.I.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2226-2227

Elsevier

Access to resources Recommend Favorite